Paul B. Rothman
Independent DirectorDr. Paul B. Rothman, MD, is Director of Merck Sharp & Dohme LLC from 2015. He serves as the served as a Director of Laboratory Corporation of America Holdings, since June 6, 2023. Dr. Rothman serves as a Venture Partner at RA Capital Management, L.P. since 2023. He is a part of Incubation team at the firm. He serves as the Dean of The Medical Faculty and Vice President for Medicine at The Johns Hopkins University and Chief Executive Officer of Johns Hopkins Medicine International, LLC. Dr. Rothman serves as an Independent Director of Labcorp Holdings Inc. since June 6, 2023. Dr. Rothman oversees both the Johns Hopkins Health System and the School of Medicine. Dr. Rothman is an emerging leader in DNA-based diagnostics. A rheumatologist and molecular immunologist, he joined Johns Hopkins in July 2012, after having served as the Dean of the Carver College of Medicine at the University of Iowa and the leader of its clinical practice plan since 2008. Previously, he served as Head of Internal Medicine at the University of Iowa from 2004 to 2008 and prior to that, was Vice Chairman for research and Founding Director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons, where he joined the faculty in 1986. Dr. Rothman's research has focused on the role cytokines play in the normal development of blood cells, as well as the abnormal development of these blood cells as a cause of hematological cancers, including leukemias. He also studied the role of cytokines in immune system responses to asthma and allergies. His work is consistently funded by the National Institutes of Health. He has been an Independent Director of Merck & Co., Inc. since September 1, 2015. He served as a Director of Cancer Genetics, Inc. from February 18, 2014 to December 2014. Dr. Rothman's honors include a James S. McDonnell Foundation Career Development Award, a Pfizer Scholars Award, a Pew Scholar Award, a Leukemia Society of America Scholar Award and the Pharmacia Allergy Research Foundation International Award in 1997. Dr. Rothman is a member of the American Society for Clinical Investigation and is a Fellow of the American College of Physicians. He was elected to the Council of Association of American Physicians, as a Fellow of the American Association for the Advancement of Sciences and as a member of the American Clinical and Climatological Association. He trained at Columbia-Presbyterian Medical Center and accepted a postdoctoral fellowship at Columbia University prior to joining its school faculty. Dr. Rothman is a 1980 Phi Beta Kappa BS graduate of the Massachusetts Institute of Technology and earned his MD from Yale University in 1984.
Positions
- Company NameLabcorp Holdings Inc.Stock CodeLHPositionIndependent DirectorColleagues
- AHAdam H. SchechterPresident, CEO & Chairman
- JAJulia A. WangExecutive VP & CFO
- BJBrian J. CaveneyExec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer
- JCJonathan C. MeltzerExecutive VP & COO
- PJPeter J. WilkinsonSenior VP & Chief Accounting Officer
- GAGarheng Albert KongVice Chairman & Lead Independent Director
- RPRichelle P. ParhamIndependent Director
- JAJeffrey A. DavisIndependent Director
- PBPaul B. RothmanIndependent Director
- Company NameMerck & Co., Inc.Stock CodeMRKPositionIndependent DirectorColleagues
- RMRobert M. DavisChairman, President & CEO
- CACaroline A. LitchfieldExecutive VP & CFO
- JLJennifer L. ZacharyExecutive VP & General Counsel
- DYDean Y. LiExecutive VP & President of Merck Research Laboratories
- DEDalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller
- THThomas Henry GlocerIndependent Lead Director
- PFPatricia F. RussoIndependent Director
- PJPamela J. CraigIndependent Director
